Updated: 2010-05-31 16:22:45
We are a successful biotechnology company and we have... lines.
Marketing Manager, Biotechnology
We are a successful biotechnology company and we have an...
From Monster - 31 May 2010 15:22:45 GMT
- job details
- View all San Diego jobs
Updated: 2010-05-31 05:33:51
provide leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, water...
From Pall Corporation - 31 May 2010 04:33:51 GMT
- job details
- View all San Diego jobs
Updated: 2010-05-30 15:17:00
life sciences and 10+ years of progressively responsible experience in a biotechnology/diagnostic environment required.
- Proven success as a scientific leader...
From VentureLoop - 30 May 2010 14:17:00 GMT
- job details
- View all San Diego jobs
Updated: 2010-05-30 14:42:10
OF THE POSITIONResponsible for all Research Biotechnology (RB) products sales and sales activities within... and proteomic research, biotechnology, pharmaceutical...
From SanDiegoRecruiter.com - 30 May 2010 13:42:10 GMT
- job details
- View all San Diego jobs
Updated: 2010-05-29 15:09:53
Scientists from Novozymes have now found the mechanism by which plectasin, an anti-microbial peptide, kills bacteria that cause severe infections in humans. Peptide antibiotics such as plectasin have retained antibiotic activity throughout evolution. The new knowledge shows that plectasin and other related peptides from invertebrates such as flies and mussels, targets the âAchilles heelâ of bacteria. Basically [...] (Source: Biosingularity)
Updated: 2010-05-28 02:01:23
© michael_swanYou understand the importance of a healthy and sharp mind. But what if you slowly became unable to recall things which were once so simple to remember?
An estimated 5.3 million people in the United States have Alzheimer's, and every 70 seconds another person develops this disease! The National Institute on Aging and the National Institutes of Health wants to raise awareness on Alzheimer's Disease by encouraging otherwise healthy volunteers with early complaints of memory problems to participate in the Alzheimer's Disease Neuroimaging ... (Source: The Biotech Weblog)
Updated: 2010-05-22 01:18:08
© CUMCTissue Engineering and Regenerative Medicine Laboratory scientists from the Dental Medicine at Columbia University Medical Center have been able to develop a potential substitute to dental implants using stem cells grown on a three-dimensional scaffold implant. The scaffold, infused with growth factor, can yield an anatomically correct tooth within nine weeks of implantation.
An animal-model study has shown that by homing stem cells to a scaffold made of natural materials and integrated in surrounding tissue, there is no need to use harvested stem cell ... (Source: The Biotech Weblog)
Updated: 2010-05-20 19:43:29
Researchers at the J. Craig Venter Institute JCVI, a not-for-profit genomic research organization, published results today describing the successful construction of the first self-replicating, synthetic bacterial cell. The team synthesized the 1.08 million base pair chromosome of a modified Mycoplasma mycoides genome. The synthetic cell is called Mycoplasma mycoides JCVI-syn1.0 and is the proof of [...] (Source: Biosingularity)
Updated: 2010-05-19 04:38:38
Submitted by BioHealth Investor Blog
by Zacks Investment Research
Cell Therapeutics, Inc. (NASDAQ: CTIC) recently decided to exchange up to 60 million shares of its common stock for $30 million of notes. Liquidity crisis at the company continues to remain a major concern for us. Earlier, in April 2010, the company raised $18.5 million through preferred stock [...]
Updated: 2010-05-19 04:29:08
Submitted by BioHealth Investor Blog
The newest initial public offering in the realm of biotech and biohealth has just been filed by a company called Ikaria Inc. While terms were not disclosed, it plans to sell up to $200 million in common stock per the SEC filing.
The New Jersey-based biotherapeutics company plans to take the ticker [...]
Updated: 2010-05-19 04:28:10
Submitted by BioHealth Investor Blog
NicOx S.A. (NYSE Euronext Paris: COX) is not a US company and only has a Pink Sheet listing. Generally we do not cover such issues, but this is one of the instances where it is merited.
Today the company’s shares were dealt a serious blow after the company confirmed that the Joint [...]
Updated: 2010-05-13 03:08:43
Submitted by BioHealth Investor Blog
Sequenom, Inc. (NASDAQ: SQNM) must really have its woes of 2009 behind it. If not, raising capital might be impossible. This morning came news that it has raised over $50 million in a private placement of securities. The problem is that this is at one hell of a discount.
The company has [...]
Updated: 2010-05-11 02:49:23
Everyone is looking for the next or the next to the next biotech and BioHealth merger candidate. Just a day after being worried about major financial losses all over again…. Morningstar has listed this week three of its favorite buyout targets in biotech from its pool of large pharmaceuticals, devices, instruments, and services companies.
Those are [...]
Updated: 2010-05-06 04:18:45
Submitted by THE HEALTH ECONOMICS BLOG
After much debate the Greek Ministry of Economy, Competitiveness & Shipping has announced a new reference pricing law for pharmaceuticals. The struggling Greek economy is looking for opportunities to realize savings in the health care sector and has introduced a decree of mandatory price reductions. Depending on wholesale price reduction [...]
Updated: 2010-05-06 04:17:24
Submitted by BioHealth Investor Blog
We were just given a cautious options alert from Joe Kunkle of OptionsHawk.com on shares of MannKind Corp. (NASDAQ: MNKD). After the unexpected meteoric rise earlier this year and then last night’s and this morning’s unexpected implosion of InterMune, it seems that traders and investors are taking a much more cautious [...]
Updated: 2010-05-05 19:40:59
We were just given a cautious options alert from Joe Kunkle of OptionsHawk.com on shares of MannKind Corp. (NASDAQ: MNKD). After the unexpected meteoric rise earlier this year and then last night’s and this morning’s unexpected implosion of InterMune, it seems that traders and investors are taking a much more cautious take on many of [...]
Updated: 2010-05-04 04:23:14
StemCells, Inc. (NASDAQ: STEM) has created some interest in the stem cell sector again on some important safety news. While today’s news is best for StemCells, Inc. (NASDAQ: STEM) as a company, this will only act to highlight others involved in stem cell research. We are also seeing moves in Geron Corporation (NASDAQ: GERN), Neostem, [...]
